Cheng-Gang Lin

Title: Cheng-Gang Lin: Innovator in Pharmaceutical Formulation

Introduction

Cheng-Gang Lin is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical formulation, particularly in the development of injectable medications. With a total of 6 patents to his name, Lin's work has had a substantial impact on the treatment of various medical conditions.

Latest Patents

One of Lin's latest patents is an aripiprazole injectable suspension formulation that boasts a prolonged shelf life. This invention is particularly relevant in the field of pharmaceutical formulation, as it addresses the need for effective treatments for schizophrenia and related diseases. The formulation not only enhances the stability of the medication but also provides methods for its use in clinical settings.

Career Highlights

Throughout his career, Cheng-Gang Lin has worked with notable companies such as Nanjing Noratech Pharmaceuticals Co., Ltd and Noratech Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the advancement of medical treatments.

Collaborations

Lin has collaborated with several professionals in his field, including Fei Liu and Li Gui. These partnerships have facilitated the exchange of ideas and fostered innovation in pharmaceutical research.

Conclusion

Cheng-Gang Lin is a distinguished inventor whose work in pharmaceutical formulation has led to significant advancements in the treatment of schizophrenia. His innovative approach and dedication to improving medication stability continue to influence the pharmaceutical industry.